Introduction
Apoptosis (programmed cell death) is a physiological mode of cell death characterized by an intact cellular membrane with chromatin condensation and degradation into discrete DNA fragments of 180 to 200 base pairs (Chiarugi et al., 1994; Huang et al., 1997) . The molecular mechanism implicated in programmed cell death has been partially elucidated and the induction of apoptosis is partly mediated intracellularly by several genes, such as p53, Bcl-2 and Bax (Chiarugi et al., 1994) . The p53 tumor suppressor gene is a cell cycle regulator, able to induce cell cycle arrest to allow DNA repair or apoptosis (Vogelstein and Kinzler, 1992) . The molecular mechanisms underlying p53 action imply transactivation of p53 dependent genes such as p21 WAF1 (El-Deiry et al., 1993) . P21 WAF1 is not only activated by the p53 protein, but it also blocks the cell cycle at G1 phase much like p53 itself. In addition, an increased level of p21 WAF1 is associated in cyclincontaining complexes with decreasing cyclin-dependent activity in damaged cells destined to apoptosis (ElDeiry et al., 1993; Harper et al., 1993) . Although its mechanism of action is still unclear, Bcl-2 functions as a suppressor of apoptotic death triggered by a variety of signals (Sedlak et al., 1995) and is negatively regulated by wild type p53. A family of genes with clear-cut homology to the Bcl-2 prototype has been identi®ed, which exhibits a paradoxical behavior, acting as apoptosis protectors or inducers. This family of proteins includes Bax, Bcl-xl, Bcl-xs, etc (Sedlak et al., 1995) . Bcl-2 overexpression has been shown to inhibit apoptosis induced by a variety of stimuli, whereas, a predominance of Bax to Bcl-2 accelerates apoptosis upon apoptotic stimuli (Williams and Smith, 1993) . Interestingly, Bax is also transactivated by p53 (Miyashita and Reed, 1995) .
12-O-tetradecanoyl-phorbol-13-acetate (TPA) is thought to be a tumor promoter, which can induce Cox-2 expression. Overexpression of Cox-2 has been reported in about 90% of colon tumors and the premalignant colorectal adenomas (Kargman et al., 1995; Sano et al., 1995) . A speci®c Cox-2 inhibitor was shown to eectively suppress the development of chemically induced aberrant crypt foci, a putative premalignant lesion (Reddy et al., 1996) . Paradoxically, TPA has also been shown to induce apoptosis in prostate cancer cells, suggesting that TPA is not only a tumor promoter, but it may serve as a potential antitumor agent in certain systems. Since breast cancer is the most commonly occurring tumor among American woman (Parker et al., 1996) , we sought to investigate the eects of TPA in breast cancer cells. Here we report for the ®rst time that treatment of breast cancer cell lines having dierent dierentiation, metastasis and p53 status with TPA, induced apoptosis with concomitant alterations in the apoptosis related gene expression.
Results

Eects of TPA on cell growth
Treatment of all ®ve breast cancer cell lines for 24 ± 72 h with 10 nM TPA resulted in inhibition of cell proliferation. The eects of TPA on the cell growth of MCF7, BT20, SKBR3, MDA-MB-231 and MDA-MB-453 cells are depicted in Figure 1 . TPA was more antiproliferative on SKBR3, MDA-MB-231 and MDA-MB-453 than on MCF7 and BT20 (MDA-MB-2314SKBR34MDA-MB-4534MCF74BT20).
Induction of cell proliferation could be the result of cell cycle growth arrest, induction of apoptosis and/or the inhibition of growth. We, therefore, investigated whether TPA could induce apoptosis in breast cancer cells.
Induction of apoptosis
TPA-induced apoptosis was observed in all ®ve cell lines as illustrated by DNA ladder shown in Figure 2 .
The induction of apoptosis was more pronounced in SKBR3, MDA-MB-231 and MDA-MB-453 cells at 48 ± 72 h, and is directly correlated with the inhibition of cell growth. Western analysis of PARP cleavage also showed that the PARP protein was degraded, with the concomitant disappearance of full size (116 KD) molecule and accumulation of the 85 KD and further degraded product of about 52 KD, in the cells after 48 h of TPA treatment (Figure 3 ). This indicated the induction of apoptosis in the time point tested. Furthermore, the data of¯ow cytometry with 7-amino actinomycin D staining showed there were much more apoptotic cells after TPA treatment for 72 h (40.25%) and 96 h (56.57%), compared to control sample (6.42%) (Figure 4 ). Subsequently, we investigated the alterations in gene expression of p53 and p53 related genes involved in the apoptotic pathway.
Expression of p21
WAF1
The expression of p21 WAF1 in all ®ve breast cancer cell lines was investigated in TPA-treated cells by Western and Northern blot analysis. The results of a typical experiment is shown in Figure 5 , demonstrating that p21 WAF1 RNA was induced within 5 h of TPA treatment and down regulated to its basic level after 24 h. Western blot analysis, whereas, showed that the levels of p21 WAF1 protein reached maximum levels at 16 h and returned to control levels by 72 h of treatment ( Figure 6 ). The induction of mRNA followed by its protein expression was directly correlated with the inhibition of cell growth.
Expression of Bcl-2 and Bax
The constitutive levels of Bcl-2 or Bax and the time course for the eect of TPA on Bcl-2 or Bax expression in the breast cancer cell lines were studied by Western and Northern blot analysis. The levels of Bcl-2 expression in the breast cancer lines were not signi®cantly aected with the addition of 10 nM TPA to the cells. In contrast, the Bax RNA was induced after 24 h of TPA treatment ( Figure 7 ) and the level of Bax protein increased signi®cantly in cells treated with TPA for 48 or 72 h ( Figure 6 ). In order to obtain a quantitative value for the protein expression of Bax and Bcl-2, optical density measurement was conducted as described under Materials and methods. The ratios of Bax to Bcl-2 protein expression revealed that cells treated with TPA showed at least a 1.5-fold increase in Bax compared to Bcl-2 (Figure 8 ).
Expression of p53
The expression of p53 in the breast cancer cell lines with and without TPA treatment was tested with Northern and Western blot analysis. As showed in Figure 5 and 6, the levels of p53 RNA and protein in the breast cancer cell lines were not aected.
Discussion
Fragmentation of cellular DNA at the internucleosomal linker regions has been observed in cells undergoing apoptosis, which was induced by a variety of agents. This cleavage produces ladders of DNA fragments that are the sizes of integer multiples of a nucleosome length (180 ± 200 bp) (Chiarugi et al., 1994; Huang et al., 1997; Fisher, 1994) . Because of their characteristic patterns revealed by agarose gel electrophoresis, these nucleosomal DNA ladders are widely used as biochemical markers of apoptosis. The cleavage of poly(ADP-ribose) polymerase (PARP) has also been used as an early marker of chemotherapy- induced apoptosis (Kaufmann et al., 1993; Lazebnik et al., 1994; Tewari et al., 1995) . Additionally,¯ow cytometry analysis with 7AAD staining now has been conducted to detect and quantitate cells undergoing apoptosis (Philpott et al., 1996; Mohammad et al., 1998) . Induction of apoptotic cell death by TPA in the prostate cancer cell line (LNCaP) has been shown previously. An increase in the number of apoptotic cells was ®rst observed at 12 h, but that DNA ladder formation was initially seen at 10 h (Sundareshan et al., 1997) . We also found similar changes in breast cancer cells treated with TPA. DNA ladder formation and PARP cleavage were observed in breast cancer cells after 48 h of treatment with TPA, and¯ow cytometry revealed that the number of apoptotic cells increased with longer treatment of TPA. The decreased cell numbers in the treatment groups compared to the control group may, indeed, be due to apoptotic cell death as well as cell growth inhibition, especially in MDA-MB-231, MDA-MB-453 and SKBR3 cells. Thus, collectively, our data suggest that TPA induces apoptosis in breast cancer cells, and that the poorly dierentiated cells and the cells with high metastatic ability are more sensitive to TPA treatment in the induction of apoptotic cell death.
The p53 tumor suppressor gene is known to be involved in apoptosis. Functional p53 can induce p21 WAF1 and an increased level of p21 WAF1 can decrease cyclin-dependent kinases (CDKs) activity, resulting in growth arrest (Vogelstein et al., 1992; El-Deiry et al., 1993; Harper et al., 1993; Polyak et al., 1996; Agarwal et al., 1995; Xiong et al., 1993) . On the other hand, p53 can down-regulate Bcl-2 which allows cells to survive a variety of fatal cellular events and protects cells from apoptosis (Sano et al., 1995; Hockenbery et al., 1993; Kane et al., 1994) . This is a typical p53-dependent pathway leading to apoptosis. In our experiment, all (MDA-MB-231, MDA-MB-453, BT 20, and SKBR3) but one (MCF 7) breast cancer cell lines harbor mutant p53. The treatment of breast cancer cells with TPA did not change the level of mutant or wild-type p53 in the cells, whereas, the p21 WAF1 in all ®ve cell lines was signi®cantly induced by TPA. These results suggest that the induction of p21 WAF1 and apoptosis by TPA is perhaps through a p53-independent pathway. Apoptosis may be induced by either a p53-dependent or independent pathway. The up-regulation of p21 WAF1 may be one of the molecular mechanisms through which TPA induces apoptosis. An increase in p21 WAF1 results in G1 arrest in the cell cycle. Cells fail to progress to S, G2 and M phase, accumulate at the G1 checkpoint, and are destined to apoptosis.
Recent studies indicate that the proto-oncogene Bax and other related proteins (Bcl-2, Bcl-xl, etc) may play a major role in determining whether cells will undergo apoptosis under certain experimental conditions, which promote cell death. Increased expression of Bax can induce apoptosis (Sano et al., 1995; Salomons et al., 1997; Kitaba et al., 1996; Findley et al., 1997) . Salomons et al., (1997) found that the ratio of Bax:Bcl-2, rather than Bcl-2 alone, is important for the survival of drug-induced apoptosis in leukemic cell lines and ALL. Our data showed that there was no signi®cant change of Bcl-2 expression and that Bax RNA and protein expressions were up-regulated in breast cancer cells treated with TPA. Thus, our results support Salomons' conclusion that the ratio of Bax and Bcl-2 protein level is important for cells undergoing apoptosis. Bax harbors a high homologic sequence of Bcl-2 and forms heterodimers with Bcl-2. Thus, Bax is a protein that antagonizes the antiapoptotic function of Bcl-2.
Previous studies also found that TPA augmented the production of pro-matrix metalloproteinases (proMMPs) and the matrix metalloproteinases (MMPs) were upregulated by TPA (Kapila et al., 1995; Cornelius et al., 1995; Rawdanowicz et al., 1994) . MMPs are a multigene family of metal-ion-requiring proteinases, which degrade components of the extracellular matrix (ECM). Recent evidence showed that ECM suppressed apoptosis of mammary epithelial cells in tissue culture and that MMPs might be involved in inducing apoptotic death (Boudreau et al., 1995; Quarrie et al., 1996; Lund et al., 1996) , leading us to propose that induction of apoptosis by TPA might be through a MMPs-mediated pathway. Much remains to be learned about the functions of MMPs to reveal the molecular mechanisms through which TPA induces apoptosis.
In conclusion, our data shows that TPA is not only a tumor promoter but also a potent inducer of apoptosis in breast cancer cells. TPA-induced apoptosis is mediated through a p53-independent pathway. TPA can up-regulate p21 WAF1 , which inhibits CDKs activity and results in G1 arrest. TPA also induces Bax, which lead breast cancer cells to be destined to apoptosis.
Material and methods
Cell culture and growth inhibition
Human breast cancer cell lines (MCF7, BT20, SKBR3, MDA-MB-231 and MDA-MB-453) were obtained from ATCC and cultured in DMEM or DMEM/H12 medium (Gibco, MD, USA) supplemented with 10% FBS, 1% penicillin/streptomycin in a 5% CO2 atmosphere at 378C. The cells were seeded at a density of 5610 5 /well in a six well culture dish. After 24 h, the cells were treated with 10 nM TPA or DMSO (vehicle control). Untreated cells and cells treated with TPA or DMSO for 24, 48, and 72 h were harvested by trypsinization, stained with 0.4% trypan blue and counted using a hemocytometer.
Protein extraction and Western blot analysis
The breast cancer cells were plated and cultured in complete medium and allowed to attach for 24 h followed by the addition of 10 nM TPA and incubation for 4, 8, 16, 24, 48 and 72 h. Control cells were incubated in the medium with DMSO for 48 h. After incubation, the cells were harvested by scraping the cells from culture dishes using a scraper and collected by centrifugation. Cells were resuspended in Tris-HCl buer, sonicated for 2610 s and lysed using an equal volume of 4% SDS. Protein concentration was then measured using protein assay reagents (Pierce, IL, USA). Cell extracts were boiled for 10 min and chilled on ice, subjected to 4 ± 20% SDS ± PAGE, and electrophoretically transferred to nitrocellulose membrane. Each membrane was incubated with monoclonal p21 WAF1 (1 : 2000, Upstate, NY, USA), Bcl-2, p53 (1 : 500, Oncogene, MA, USA), Polyclonal Bax (1 : 500, Oncogene, MA, USA), b-actin (1 : 2000, Sigma, MO, USA) antibodies, washed with TTBS and incubated with secondary antibody conjugated with peroxidase. The signal was then detected using chemiluminescent detection system (Pierce, IL, USA). Bidimentional optical densities (OD) of p21WAF1, Bcl-2, Bax, p53 and actin proteins in the ®lms were scanned by Gel Doc 1000 (Bio-Rad, CA, USA) and quanti®ed by Molecular Analyst software (BioRad, CA, USA).
RNA extraction and Northern blot analysis
After treatment with TPA for 5, 24 and 48 h or with DMSO for 5 and 48 h, the treated and untreated cells were harvested and total RNA was extracted using TRIzol RNA extraction kit (Gibco, MD, USA). 20 mg total RNA of each sample was electrophoresed on a 1.2% agaroseformaldehyde gel. After transfer to a nylon membrane, hybridization was performed with a-32 P-labeled p21 WAF1 , p53 and Bax cDNA probe. The membranes were subsequently hybridized with b-actin cDNA probe to monitor RNA loading.
DNA ladder formation
Cellular cytoplasmic DNA from cells treated with TPA for 24, 48, 72 h or with DMSO for 48 h, was extracted using 10 mM Tris (pH 8.0), 1 mM EDTA, and 0.2% Triton X-100. The lysate was centrifuged for 15 min at 13 000 g to separate the fragment DNA (soluble) from intact chromatin (nuclear pellet). The supernatant from the lysate was treated with RNase, followed by SDSProteinase K digestion, phenol chloroform extraction and isopropanol precipitation. DNA was separated through a 1.5% agarose gel. After electrophoresis, gels were stained with ethidium bromide and the DNA was visualized by UV light.
Analysis of cleavage of PARP
Cells treated with TPA or DMSO for 24, 48, 72 h were lysed in lysis buer [10 mM Tris-HCl (pH 7.1), 50 mM sodium chloride, 30 mM sodium pyrophosphate, 50 mM sodium¯uoride, 100 mM sodium orthovanadate, 2 mM iodoacetic acid, 5 mM ZnCl 2 , 1 mM phenylmethylsulfonyl uoride, and 0.5% Triton X-100]. The lysates were kept on ice for 30 min and vigorously vortexed before centrifugation at 12 500 g for 20 min. Fifty mg of total protein were resolved on 10% SDS-PAGE and then transferred to membrane. The membrane was incubated with primary monoclonal anti-human PARP antibody (1 : 5000, Biomol, PA, USA), washed with TTBS and incubated with secondary antibody conjugated with peroxidase. The signal was then detected using chemiluminescent detection system (Pierce, IL, USA).
Flow cytometry for detecting apoptosis
7-amino actinomycin D (7AAD) staining and¯ow cytometry was conducted to detect and quantitate apoptosis as described previously (Philpott et al., 1996) . Cells treated with TPA for 72 and 96 h or with DMSO for 96 h were subject to this analysis. Brie¯y, 7AAD (Calbiochem-Novabiochem, CA, USA) was dissolved in acetone and diluted in PBS to a concentration of 200 mg/ ml. A total of 100 ml of 7AAD solution was added to 10 6 cells suspended in 1 ml PBS and mix well. Cells were stained for 20 min at 48C while protected from light and pelleted by centrifugation. The cells were resuspended in 500 ml of 2% paraformaldehyde (PE) solution. Unstained ®xed cells were used as negative control. Samples were analysed on a FACscan (Becton Dickinson, CA, USA) within 30 min of ®xation. Data on 10 000 and 20 000 cells were acquired and processed using Lysys II software (Becton Dickinson, CA, USA). Scattergrams were generated by combining forward light scatter with 7AAD uorescence, and regions were drawn around clear-cut populations having negative, dim, and bright¯uorescence. The frequency of cells with low, medium, and high 7AAD uorescence was assessed. The purity and enrichment of the sorted populations were then calculated.
